Friday 6-20-2014 Gilead Sciences (GILD) $GILD opened at

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday 6-20-2014 Gilead Sciences (GILD) $GILD opened at 80.14 hitting the high price of 81.55 and a day low of 79.68 with a total volume of 17,946,359. GILD had a previous close of 79.78 and has been seeing an average volume of 10,486,800.

Overall Average: 32% Buy

Recent stock forum discussions about GILD http://investorshangout.com/search?q=GILD&...mp;yt0=Go!

Final Glance: Biotechnology companies
AP - Fri Jun 20, 5:05PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading: (full story)

Is Gilead Sciences, Inc. Destined for Greatness?
Alex Planes, The Motley Fool - Motley Fool - Fri Jun 20, 5:00PM CDT
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable market-beating gains, with robust and improving financial metrics that support strong price... (full story)

AstraZeneca's Naloxegol Data Published - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 5:00PM CDT
AstraZeneca (AZN) announced that data related to its opioid-induced constipation candidate, naloxegol, was published in the New England Journal of Medicine. (full story)

Alnylam-TAP Collaborate for AAT Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 3:45PM CDT
Alnylam Pharmaceuticals (ALNY) inked a collaboration deal with TAP for the continued development of ALN-AAT. (full story)

OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 2:50PM CDT
OncoMed Pharmaceuticals Inc. (OMED) recently suffered another setback when the FDA had placed a partial clinical hold on phase I clinical trials of another pipeline candidate, OMP-54F28. (full story)

Merge Healthcare: Updated Research Report - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 1:55PM CDT
On Jun 20, 2014, we issued an updated research report on Merge Healthcare Incorporated (MRGE). (full story)

Illumina: Updated Research Report - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 1:30PM CDT
On Jun 20, 2014, we issued an updated research report on life sciences company Illumina Inc. (ILMN). (full story)

Midday Glance: Biotechnology companies
AP - Fri Jun 20, 12:26PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.: (full story)

Achillion Could Win Idenix's Mystery Suitor: Analyst
at Investor's Business Daily - Fri Jun 20, 11:44AM CDT
Hot biotech stock Achillion Pharmaceuticals (ACHN) was up 2%, near 8.20, in midday trading in the stock market today after an analyst found more support for its prospects as a buyout candidate. R. W. Baird's Brian Skorney noted that Merck's (MRK)... (full story)

Better Stock Today Challenge: Gilead vs. DistributionNow
David Williamson and Joel South, The Motley Fool - Motley Fool - Fri Jun 20, 11:40AM CDT
In the spirit of World Cup competition, we're holding our own tournament in search of the Better Stock Today. We're pitting 32 companies against each other and you, the reader, will determine the winner. Today it's the round of 16, and   Gilead  ... (full story)

Celgene Rises on Yet Another Stock Split - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 10:30AM CDT
Shares of Gelgene (CELG) gained following the approval of a stock split. (full story)

Gilead Sciences (GILD) Crosses Pivot Point Resistance at $80.56
Comtex SmarTrend(R) - Fri Jun 20, 10:12AM CDT
Shares of Gilead Sciences (NASDAQ:GILD) have bullishly opened above the pivot of $79.72 today and have reached the first resistance level of $80.56. Should the shares continue to rise, the resistance pivots of $81.34 and $82.96 will be of interest. (full story)

Cubist Gets Priority Review from FDA for Antibiotic Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 10:00AM CDT
The FDA will review Cubist's (CBST) ceftolozane/tazobactam on a priority basis . (full story)

Early Glance: Biotechnology companies
AP - Fri Jun 20, 9:35AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.: (full story)

'Mad Money' Lightning Round: Buy, Buy, Buy Stryker
at The Street - Fri Jun 20, 5:00AM CDT
Cramer prefers Celgene over Gilead Sciences, Palo Alto Networks over OSI Systems and is discouraged by IBM. (full story)

Jim Cramer's 'Mad Money' Recap: Management Matters, Not the Fed
at The Street - Thu Jun 19, 6:57PM CDT
People obsessed with the Fed have kept you out of the market, Cramer said, and the Fed's bond buyback tapering is simply not having an impact. (full story)

Protalix Drug in Phase IIa Study for Gaucher Disease - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 5:15PM CDT
Protalix BioTherapeutics, Inc. (PLX) has enrolled the first patient in a phase IIa study on PRX-112 (oral GCD) for the treatment of Gaucher disease. (full story)

BioLineRx to Commence BL-8040 Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 5:10PM CDT
BioLineRx Ltd. (BLRX) announced that the Israeli Ministry of Health informed the company that it can start a phase I study on its oncology candidate, BL-8040. (full story)

Valeant Launches Hostile Bid for Allergan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 4:50PM CDT
Valeant Pharmaceuticals International, Inc. (VRX) announced that it has commenced an exchange offer for the common stock of Allergan, Inc (AGN). (full story)

Gilead Sciences Inc. (GILD) Stock Research Links

GILD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

West Texas Weather Shapes Home Design Decisions

Updated Category News Views 2

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading
Everpure Surges into the S&P 500: A Milestone Move

Updated Category News Views 2

Big Leagues Beckon: Everpure Enters the S&P 500 Another day, another dollar, but today ain't just any day for Everpure. They’re stepping up from the minor leagues and grabbing their spot in the illustrious S&P 500 lineup. We're talking about a milestone that every company dreams of, but few achieve—this ain't your regular Tuesday headline. Stock Market's Stamp of...

Continue Reading
Spot the Signs: Early Gum Disease Insights from Experts

Updated Category News Views 2

Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....

Continue Reading
The Austin Company to Showcase at ISPE Annual Event

Updated Category News Views 0

Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...

Continue Reading
India's First Upright Proton Therapy System Unveiled

Updated Category News Views 3

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Continue Reading
Intellectia.AI Transforming Trading with AI Upgrades

Updated Category News Views 1

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...

Continue Reading
BrightPlan's AI-Powered Growth: Series C Fuel

Updated Category News Views 3

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Continue Reading
Life Flower Celebrates 16 Years with Dog Adoption Event

Updated Category News Views 2

A Celebration with Heart Ah, the classic mix of business and community goodwill—that's what Life Flower Dispensary is all about this year. You know, not every business that hits the 16-year mark decides to make it about something bigger than just slashing prices or hyping themselves up. But Life Flower? They're using their anniversary to throw a shindig that's more than...

Continue Reading
Leidos' Autonomous Vessels Chart Bold Naval Waters

Updated Category News Views 1

Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...

Continue Reading
Tiger Group to Auction Huge Window Manufacturing Plant

Updated Category News Views 2

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

Continue Reading

Top 5 Most Recently Viewed Articles

Copper Giant Resources Secures C$5.8 Million from Public Offering

Updated Category News Views 129

Copper Giant Resources Closes Successful Public Offering Copper Giant Resources Corp. (TSXV: CGNT) has recently completed its public offering, raising a total of C$5.8 million in gross proceeds. This marks a significant milestone for the company as it aims to fuel its ongoing exploration and development efforts. The offering, conducted under best efforts, was led by Red...

Continue Reading
Bath & Body Works Boosts Sales Outlook Amid Strong Demand

Updated Category News Views 86

Bath & Body Works Raises Sales Expectations Bath & Body Works (NYSE: BBWI) is showing signs of resilience in a challenging retail environment. The company recently announced a more optimistic forecast for its full-year adjusted profit, predicting a smaller decline in annual sales than previously expected. This positive shift in outlook is largely attributed to strong...

Continue Reading
Fenchurch General Insurance Company Receives A- Credit Ratings

Updated Category News Views 249

Fenchurch General Insurance Company Achieves Notable Credit Ratings Fenchurch General Insurance Company, established in 1981, has made headlines with its recent credit ratings assigned by AM Best. The company has been awarded a Financial Strength Rating of A- (Excellent) along with a Long-Term Issuer Credit Rating of 'a-' (Excellent). This positive recognition plays a...

Continue Reading
GTT Updates on Share Capital and Voting Rights Analysis

Updated Category News Views 282

Understanding GTT's Share Capital and Voting Rights GTT is committed to ensuring transparency regarding its share capital and the voting rights associated with its shares. This article discusses the updated figures and their implications for investors and stakeholders. Latest Voting Rights and Share Count As of the latest report, the total count of shares stood at an...

Continue Reading
Agios Pharmaceuticals Welcomes New Chief Corporate Officer

Updated Category News Views 281

Agios Pharmaceuticals Announces New Leadership Role Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a prominent name in the field of cellular metabolism, is embarking on an exciting chapter with the recent appointment of Krishnan Viswanadhan as its Chief Corporate Development & Strategy Officer. This strategic addition is vital as Agios continues to innovate in therapies for...

Continue Reading